Table 2 Concurrent medications (N = 232)
Medication Class | All Patients (N = 232) n (%) | Torsemide Users (N = 45) n (%) | Optimized Furosemide Users (N = 187), n (%) | P-value |
|---|---|---|---|---|
ACE Inhibitor | 81 (34.9) | 12 (26.7) | 69 (36.9) | 0.2 |
ABR | 56 (24.1) | 8 (17.8) | 48 (25.7) | 0.27 |
Thiazide Diuretic | 6 (2.6) | 1 (2.2) | 5 (2.7) | 1.0‡ |
Thiazide-Like Diuretic | 20 (8.6) | 7 (15.6) | 13 (7.0) | 0.08‡ |
Beta-Blocker | 207 (89.2) | 37 (82.2) | 170 (90.9) | 0.11‡ |
Aldosterone Antagonist | 84 (36.2) | 20 (44.4) | 64 (34.2) | 0.2 |
Dihydropyridine CCB | 65 (28.0) | 10 (22.2) | 55 (29.4) | 0.34 |
Non-Dihydropyridine CCB | 6 (2.6) | 1 (2.2) | 5 (2.7) | 1.0‡ |
Hydralazine | 63 (27.2) | 13 (28.9) | 50 (26.7) | 0.8 |
Nitrate | 102 (44.0) | 18 (40.0) | 84 (44.9) | 0.55 |
Digoxin | 28 (12.1) | 4 (8.9) | 24 (12.8) | 0.47 |
Ivabradine | 6 (2.6) | 0 (0.0) | 6 (3.2) | 0.6‡ |
Sacubitril/Valsartan | 4 (1.7) | 1 (2.2) | 3 (1.6) | 0.58‡ |
Diuretic TDD (mg) | 108 ± 48 | 96 ± 54 | 110 ± 46 | 0.07 |